You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Details for Patent: 10,646,500


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,646,500
Title:Treatment of allergic rhinitis using a combination of mometasone and olopatadine
Abstract: The present patent application relates to a method of treating allergic rhinitis in a subject (preferably a human) by administering a combination of mometasone or its salt and olopatadine or its salt.
Inventor(s): Khairatkar-Joshi; Neelima (Thane, IN), Kulkarni; Abhay (Navi Mumbai, IN), Wale; Dinesh Pradeep (Osmanabad, IN), Bhosale; Vikram Mansingh (Mumbai, IN), Agarwal; Piyush (Mumbai, IN), Keohane; Patrick (London, GB), Tantry; Sudeesh K. (Jamison, PA), Oh; Chad (Mahwah, NJ)
Assignee: GLENMARK SPECIALTY S.A. (La Chaux-de-Fonds, CH)
Application Number:14/506,122
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation;

Drugs Protected by US Patent 10,646,500

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Glenmark Specialty RYALTRIS mometasone furoate; olopatadine hydrochloride SPRAY, METERED;NASAL 211746-001 Jan 13, 2022 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial TREATMENT OF SEASONAL ALLERGIC RHINITIS BY NASALY ADMINISTERING A COMBINATION OF OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,646,500

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
India3174/MUM/2013Oct 4, 2013

International Family Members for US Patent 10,646,500

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2018260934 ⤷  Try a Trial
Australia 2019224850 ⤷  Try a Trial
Brazil 112015018252 ⤷  Try a Trial
Brazil 112018076537 ⤷  Try a Trial
Brazil 112020016817 ⤷  Try a Trial
Canada 3023355 ⤷  Try a Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.